An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening

Fatima Amanat; Kris M White; Lisa Miorin; Shirin Strohmeier; Meagan McMahon; Philip Meade; Wen-Chun Liu; Randy A Albrecht; Viviana Simon; Luis Martinez-Sobrido; Thomas Moran; Adolfo García-Sastre; Florian Krammer

doi:10.1002/cpmc.108

An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening

Curr Protoc Microbiol. 2020 Sep;58(1):e108. doi: 10.1002/cpmc.108.

Authors

Fatima Amanat^{1

2}, Kris M White^{2

3}, Lisa Miorin^{2

3}, Shirin Strohmeier², Meagan McMahon², Philip Meade^{1

2}, Wen-Chun Liu^{2

3}, Randy A Albrecht^{2

3}, Viviana Simon^{2

3

4}, Luis Martinez-Sobrido⁵, Thomas Moran², Adolfo García-Sastre^{2

3

4

6}, Florian Krammer²

Affiliations

¹ Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
² Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York.
³ Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
⁵ Texas Biomedical Research Institute, San Antonio, Texas.
⁶ Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in the city of Wuhan, Hubei Province, China, in late 2019. Since then, the virus has spread globally and caused a pandemic. Assays that can measure the antiviral activity of antibodies or antiviral compounds are needed for SARS-CoV-2 vaccine and drug development. Here, we describe in detail a microneutralization assay, which can be used to assess in a quantitative manner if antibodies or drugs can block entry and/or replication of SARS-CoV-2 in vitro. © 2020 Wiley Periodicals LLC. Basic Protocol 1: Microneutralization assay to test inhibition of virus by antibodies (purified antibodies or serum/plasma) Basic Protocol 2: Screening of anti-SARS-CoV-2 compounds in vitro Support Protocol: SARS-CoV-2 propagation.

Keywords: COVID-19; COVID19; SARS-CoV-2; antivirals; medium-throughput screening; microneutralization; neutralization.

MeSH terms

Animals
Antibodies, Viral / immunology*
Betacoronavirus / immunology*
COVID-19
Chlorocebus aethiops
Coronavirus Infections / immunology
Coronavirus Infections / virology
Drug Evaluation, Preclinical / methods*
Humans
Mice
Neutralization Tests / methods*
Pandemics
Pneumonia, Viral / immunology
Pneumonia, Viral / virology
SARS-CoV-2
Vero Cells
Virus Internalization / drug effects
Virus Replication / drug effects

Substances

Antibodies, Viral

Abstract

MeSH terms

Substances

Grants and funding